Examples of 'renal impairment see' in a sentence
Meaning of "renal impairment see"
Renal impairment see - Refers to a medical condition characterized by decreased or compromised kidney function, often leading to issues with filtering waste and excess fluids from the blood. Symptoms of renal impairment can include swelling, fatigue, changes in urination, and high blood pressure. It requires proper diagnosis and management by healthcare professionals
How to use "renal impairment see" in a sentence
Basic
Advanced
renal impairment see
Rimonabant should not be used in patients with severe renal impairment see section dic.
Patients with renal impairment see section 4.4 Fluid retention and cardiac failure.
Dosage adjustments are necessary in subjects with renal impairment see DOSAGE AND ADMINISTRATION.
No Lamivudine / Zidovudine Teva dosage adjustment necessary, unless patient has renal impairment See Section.
Contraindicated in patients with renal impairment see section 4.3.
No dose adjustment is required for darunavir / ritonavir in patients with renal impairment see sections.
A lower starting dose is required in the presence of renal impairment see Table 1 below.
Modified-release levodopa / carbidopa should be administered cautiously to patients with severe renal impairment see section 4.2.
Cholib is contraindicated in moderate to severe renal impairment see section 4.3.
No dosage adjustment is necessary based on renal impairment see section 5.2.
No data are available in subjects with severe renal impairment see section 4.2.
No data are available in patients with severe renal impairment see section 4.2.
The effect of erythromycin is additive to that of renal impairment see section 4.4.
Therapeutic experience is limited in patients with renal impairment see section 4.4.
Cetrorelix is contraindicated in patients with severe renal impairment see section 4.3.
Caution is advised in treatment of patients with hepatic or renal impairment see section 4.4.
Particularly careful monitoring is required in patients with renal impairment see section 4.2.
Limited data are available in patients with severe renal impairment see section 5.2.
Dose adjustment is not needed in patients with renal impairment see section 5.2.
No dosage adjustment is required for patients with renal impairment see section 5.2.
No dose adjustment is considered necessary in patients with renal impairment see section 5.2.
Caution should be exercised in patients with severe renal impairment see section 4.4.
Fesoterodine and solifenacin are contraindicated in patients with renal impairment see section 4.3.
Xeplion has not been systematically studied in patients with renal impairment see section 5.2.
No dose adjustments are required for patients with hepatic or renal impairment see section 5.2.
Dosing adjustment is necessary in patients with moderate or severe renal impairment see section 4.2.
However, insulin requirements may be reduced in the presence of renal impairment see section 5.2.
However, caution should be used in patients with severe renal impairment see section 4.2.
Repatha has not been studied in patients with severe renal impairment see section 4.4.
Therapeutic experience is limited in patients with mild to moderate renal impairment see section 4.4.
Dosage adjustment is necessary in patients with moderate and severe renal impairment see section 4.2.
Temsirolimus should be used with caution in patients with severe renal impairment see section 4.4.
There are only limited data available in patients with severe renal impairment see section 5.2.
Preotact should therefore not be used in patients with severe renal impairment see section 4.3.
Lynparza dose adjustment is recommended for patients with moderate renal impairment see section 4.2.
Renal impairment, dosage adjustment is recommended for patients with renal impairment see section 4.2.
Dose adjustments are not recommended in patients with mild or moderate renal impairment see section 5.2.
Dose adjustment is necessary in patients with moderate and severe renal impairment see section 4.2.
Dose adjustments are recommended in patients with moderate and severe renal impairment see section 4.2.
Trametinib should be used with caution in patients with severe renal impairment see sections 4.2 and.
SIMBRINZA is contraindicated in patients with severe renal impairment see section 4.3.
FORSTEO should not be used in patients with severe renal impairment see 4.3.
Renal impairment Therapeutic experience is limited in patients with renal impairment see section 4.4.
TREVICTA has not been systematically studied in patients with renal impairment see section 5.2.
EVISTA should not be used in patients with severe renal impairment see section 4.3.
No dose adjustment of Vitekta is required for patients with renal impairment see section 5.2.
KEYTRUDA has not been studied in patients with severe renal impairment see section 5.2.
DuoPlavin must not be used in patients with severe renal impairment see section 4.3.
FORSTEO must not be used in patients with severe renal impairment see section 4.3.
Renal impairment No dosage adjustment is required for patients with renal impairment see section 5.2.
You'll also be interested in:
Examples of using Renal
Show more
He had some renal issues last year
Renal perfusion and circulation time are reduced
The kid had a renal artery thrombosis
Examples of using See
Show more
Press or to see the rest of the options
See that the stone is securely fastened
I can not see you back there
Examples of using Impairment
Show more
An impairment test is realized during each closing
You have a neurological impairment called somatoparaphrenia
Impairment testing is done at the individual investment level
